Project Grant 2440535
Award Date
3/1/25
Completion Date
2/28/30
Dollars Obligated
$240K
Federal Agency
Division of Molecular and Cellular Biosciences
Federal Grant Program
47.074
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This National Science Foundation Project Grant of $649,998 will fund research into adaptive and regulatory diversity in natural CRISPR-Cas systems from March 1, 2023 to February 29, 2028. The grant was awarded under the Biological Sciences program (CFDA 47.074) to further the program's goals of advancing the biological sciences and strengthening the Nation's scientific enterprise. The University of Washington will investigate the mechanisms by which diverse CRISPR systems acquire immunological...
This $509,070 Project Grant award from the National Science Foundation's Division of Molecular and Cellular Biosciences (CFDA 47.074 Biological Sciences) supports research at Purdue University to explore the working mechanism of CRISPR-Cas12 endonucleases and analogues. The primary goals are to investigate the regulatory mechanisms of natural CRISPR inhibitor proteins, and to dissect the structural dynamics of newly identified Cas12 analogues found in mobile genetic elements and viruses. This...
This National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) Project Grant award of $240,000 will fund a 3-year postdoctoral fellowship to research the adaptive response of bacteria to bacteriophage infection and high hydrostatic pressure. The fellow will develop novel fluorescence microscopy techniques to quantify bacterial growth, cell size, and morphology under these environmental stressors using model organisms E. coli, P. aeruginosa, and S. piezotolerans. The project...
The National Science Foundation (NSF) awarded a $800,000 Project Grant under its Biological Sciences program (CFDA 47.074) to The Regents of the University of California, doing business as University of California, Berkeley. The grant funding will support collaborative research to discover and characterize compact CRISPR gene editing systems that can be encoded in plant viruses. This will enable more efficient and widespread deployment of genome editing capabilities across a variety of crop...
This five-year $385,645 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) will fund research investigating RNA-guided nucleases encoded by transposons across the three domains of life. The grantee, Columbia University, will examine an ancestral family of transposon-encoded enzymes that use guide RNAs to target and cut matching DNA sequences. These enzymes are directly related to CRISPR-Cas9 and CRISPR-Cas12 genome editing tools. The project aims to...
This $360,247 federal Project Grant award was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) to Rutgers, The State University of New Jersey. The funding supports research focused on exploring the diverse mechanisms of Type III CRISPR-Cas signaling in microbes, including bacteria and archaea. The research aims to investigate the function and regulation of CRISPR signaling effectors, particularly...
The National Science Foundation awarded a two-year, $138,000 Project Grant under the Biological Sciences federal grant program (CFDA 47.074) to conduct research characterizing the genetic mechanisms of bacteria-phage coevolution in Listeria and Salmonella. The postdoctoral fellow will analyze the dynamic relationships between the foodborne pathogens Listeria monocytogenes and Salmonella enterica, and their bacteriophages. Through serial passaging experiments and whole genome sequencing, the...
The National Science Foundation awarded a $199,999 Project Grant under the Engineering (CFDA 47.041) program to The Trustees of the University of Pennsylvania to develop a next-generation RNA detection tool for infectious disease diagnosis. The project aims to engineer a thermostable version of the CRISPR-Cas13 enzyme to improve its stability and sensitivity for field applications. By combining the enhanced Cas13 enzyme with advanced electrochemical devices, the researchers will create an...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $273,652 to Phage Refinery LLC aims to develop a rapid and efficient parametric model for predicting the likelihood that a given bacteriophage (phage) will survive sufficiently long in the presence of an active immune system to be effective as a treatment against their target bacterial infection. The project will gather physical parameters and in-vivo persistence data for 400...
This $1,000,000.00 Project Grant awarded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to characterize the molecular mechanisms by which the bridge helix (BH) region of the CRISPR-associated (Cas) 9 and Cas12a enzymes contributes to DNA cleavage fidelity. The overarching goal is to develop error-proof variants of these genome editing tools that minimize unintended off-target DNA modifications. The award includes a sub-grant to the University...